Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Colorcon
McKinsey
Covington
Fuji
QuintilesIMS
Chinese Patent Office
Dow

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087835

« Back to Dashboard

NDA 087835 describes OXTRIPHYLLINE, which is a drug marketed by Morton Grove and Watson Labs and is included in four NDAs. Additional details are available on the OXTRIPHYLLINE profile page.

The generic ingredient in OXTRIPHYLLINE is oxtriphylline. There are three drug master file entries for this compound. Additional details are available on the oxtriphylline profile page.
Summary for 087835
Tradename:OXTRIPHYLLINE
Applicant:Watson Labs
Ingredient:oxtriphylline
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, DELAYED RELEASE;ORALStrength200MG
Approval Date:Aug 25, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Colorcon
McKesson
QuintilesIMS
Covington
Merck
Daiichi Sankyo
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.